1953 – FDA approves Delatestryl to treat conditions associated with a deficiency or absence of testosterone.
1953 – FDA approves Delatestryl
Announcement Date: January 1, 1953
1953 – FDA approves Delatestryl to treat conditions associated with a deficiency or absence of testosterone.